nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—Brinzolamide—glaucoma	0.406	1	CrCtD
Dorzolamide—CA5A—glaucoma	0.105	0.513	CbGaD
Dorzolamide—CA1—glaucoma	0.0564	0.277	CbGaD
Dorzolamide—CA2—glaucoma	0.0428	0.21	CbGaD
Dorzolamide—CA14—Diclofenamide—glaucoma	0.00966	0.0354	CbGbCtD
Dorzolamide—CA14—Brinzolamide—glaucoma	0.00966	0.0354	CbGbCtD
Dorzolamide—CA6—Brinzolamide—glaucoma	0.00918	0.0336	CbGbCtD
Dorzolamide—CA5A—Brinzolamide—glaucoma	0.00918	0.0336	CbGbCtD
Dorzolamide—CA5A—Diclofenamide—glaucoma	0.00918	0.0336	CbGbCtD
Dorzolamide—CA6—Diclofenamide—glaucoma	0.00918	0.0336	CbGbCtD
Dorzolamide—CA14—Methazolamide—glaucoma	0.00832	0.0305	CbGbCtD
Dorzolamide—CA5B—Brinzolamide—glaucoma	0.008	0.0293	CbGbCtD
Dorzolamide—CA7—Brinzolamide—glaucoma	0.008	0.0293	CbGbCtD
Dorzolamide—CA5B—Diclofenamide—glaucoma	0.008	0.0293	CbGbCtD
Dorzolamide—CA7—Diclofenamide—glaucoma	0.008	0.0293	CbGbCtD
Dorzolamide—CA6—Methazolamide—glaucoma	0.0079	0.0289	CbGbCtD
Dorzolamide—CA5A—Methazolamide—glaucoma	0.0079	0.0289	CbGbCtD
Dorzolamide—CA7—Methazolamide—glaucoma	0.00688	0.0252	CbGbCtD
Dorzolamide—CA5B—Methazolamide—glaucoma	0.00688	0.0252	CbGbCtD
Dorzolamide—CA12—Diclofenamide—glaucoma	0.00686	0.0251	CbGbCtD
Dorzolamide—CA9—Diclofenamide—glaucoma	0.00686	0.0251	CbGbCtD
Dorzolamide—CA9—Brinzolamide—glaucoma	0.00686	0.0251	CbGbCtD
Dorzolamide—CA12—Brinzolamide—glaucoma	0.00686	0.0251	CbGbCtD
Dorzolamide—CA14—Acetazolamide—glaucoma	0.00665	0.0243	CbGbCtD
Dorzolamide—CA1—Brinzolamide—glaucoma	0.00642	0.0235	CbGbCtD
Dorzolamide—CA1—Diclofenamide—glaucoma	0.00642	0.0235	CbGbCtD
Dorzolamide—CA5A—Acetazolamide—glaucoma	0.00632	0.0231	CbGbCtD
Dorzolamide—CA6—Acetazolamide—glaucoma	0.00632	0.0231	CbGbCtD
Dorzolamide—CA4—Diclofenamide—glaucoma	0.00604	0.0221	CbGbCtD
Dorzolamide—CA4—Brinzolamide—glaucoma	0.00604	0.0221	CbGbCtD
Dorzolamide—CA12—Methazolamide—glaucoma	0.00591	0.0216	CbGbCtD
Dorzolamide—CA9—Methazolamide—glaucoma	0.00591	0.0216	CbGbCtD
Dorzolamide—CA2—Diclofenamide—glaucoma	0.00555	0.0203	CbGbCtD
Dorzolamide—CA2—Brinzolamide—glaucoma	0.00555	0.0203	CbGbCtD
Dorzolamide—CA1—Methazolamide—glaucoma	0.00553	0.0202	CbGbCtD
Dorzolamide—CA5B—Acetazolamide—glaucoma	0.0055	0.0202	CbGbCtD
Dorzolamide—CA7—Acetazolamide—glaucoma	0.0055	0.0202	CbGbCtD
Dorzolamide—CA4—Methazolamide—glaucoma	0.0052	0.019	CbGbCtD
Dorzolamide—CA2—Methazolamide—glaucoma	0.00478	0.0175	CbGbCtD
Dorzolamide—CA9—Acetazolamide—glaucoma	0.00472	0.0173	CbGbCtD
Dorzolamide—CA12—Acetazolamide—glaucoma	0.00472	0.0173	CbGbCtD
Dorzolamide—CA1—Acetazolamide—glaucoma	0.00442	0.0162	CbGbCtD
Dorzolamide—CA4—Acetazolamide—glaucoma	0.00416	0.0152	CbGbCtD
Dorzolamide—CA2—Acetazolamide—glaucoma	0.00382	0.014	CbGbCtD
Dorzolamide—CA6—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00106	0.0281	CbGpPWpGaD
Dorzolamide—CA5A—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00106	0.0281	CbGpPWpGaD
Dorzolamide—CA14—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000998	0.0264	CbGpPWpGaD
Dorzolamide—Brinzolamide—CA5A—glaucoma	0.000993	0.513	CrCbGaD
Dorzolamide—CA5B—Reversible hydration of carbon dioxide—CA1—glaucoma	0.000993	0.0262	CbGpPWpGaD
Dorzolamide—CA7—Reversible hydration of carbon dioxide—CA1—glaucoma	0.000993	0.0262	CbGpPWpGaD
Dorzolamide—CYP2C9—Diclofenamide—glaucoma	0.00098	0.00359	CbGbCtD
Dorzolamide—CA6—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000972	0.0257	CbGpPWpGaD
Dorzolamide—CA5A—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000972	0.0257	CbGpPWpGaD
Dorzolamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA1—glaucoma	0.000923	0.0244	CbGpPWpGaD
Dorzolamide—CA12—Reversible hydration of carbon dioxide—CA1—glaucoma	0.00092	0.0243	CbGpPWpGaD
Dorzolamide—CA5B—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000908	0.024	CbGpPWpGaD
Dorzolamide—CA7—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000908	0.024	CbGpPWpGaD
Dorzolamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA1—glaucoma	0.000885	0.0234	CbGpPWpGaD
Dorzolamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—glaucoma	0.000844	0.0223	CbGpPWpGaD
Dorzolamide—CYP2C9—Methazolamide—glaucoma	0.000844	0.00309	CbGbCtD
Dorzolamide—CA12—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000841	0.0222	CbGpPWpGaD
Dorzolamide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—glaucoma	0.000776	0.0205	CbGpPWpGaD
Dorzolamide—CA4—Reversible hydration of carbon dioxide—CA1—glaucoma	0.000733	0.0194	CbGpPWpGaD
Dorzolamide—CYP3A4—Pilocarpine—glaucoma	0.000726	0.00266	CbGbCtD
Dorzolamide—CA2—Reversible hydration of carbon dioxide—CA1—glaucoma	0.000703	0.0186	CbGpPWpGaD
Dorzolamide—CA4—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000671	0.0177	CbGpPWpGaD
Dorzolamide—CA1—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000616	0.0163	CbGpPWpGaD
Dorzolamide—CA9—Reversible hydration of carbon dioxide—CA1—glaucoma	0.000593	0.0157	CbGpPWpGaD
Dorzolamide—CYP3A4—Brinzolamide—glaucoma	0.00057	0.00209	CbGbCtD
Dorzolamide—CA9—Reversible hydration of carbon dioxide—CA2—glaucoma	0.000542	0.0143	CbGpPWpGaD
Dorzolamide—Brinzolamide—CA1—glaucoma	0.000535	0.277	CrCbGaD
Dorzolamide—CYP3A4—Methazolamide—glaucoma	0.000491	0.0018	CbGbCtD
Dorzolamide—Brinzolamide—CA2—glaucoma	0.000406	0.21	CrCbGaD
Dorzolamide—CYP3A4—Acetazolamide—glaucoma	0.000392	0.00144	CbGbCtD
Dorzolamide—CYP3A4—Clonidine—glaucoma	0.000355	0.0013	CbGbCtD
Dorzolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—glaucoma	0.000105	0.00279	CbGpPWpGaD
Dorzolamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	8.33e-05	0.0022	CbGpPWpGaD
Dorzolamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	7.58e-05	0.002	CbGpPWpGaD
Dorzolamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	5e-05	0.00132	CbGpPWpGaD
Dorzolamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	4.89e-05	0.00129	CbGpPWpGaD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—EDN1—glaucoma	4.88e-05	0.00129	CbGpPWpGaD
Dorzolamide—CA9—Cellular response to hypoxia—VEGFA—glaucoma	4.66e-05	0.00123	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CA5A—glaucoma	4.54e-05	0.0012	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NARFL—glaucoma	4.54e-05	0.0012	CbGpPWpGaD
Dorzolamide—CA1—C-MYB transcription factor network—GSTM1—glaucoma	4.52e-05	0.00119	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CA5A—glaucoma	4.42e-05	0.00117	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NARFL—glaucoma	4.42e-05	0.00117	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NARFL—glaucoma	4.42e-05	0.00117	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CA5A—glaucoma	4.13e-05	0.00109	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NARFL—glaucoma	4.13e-05	0.00109	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NARFL—glaucoma	4.13e-05	0.00109	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CA5A—glaucoma	4.13e-05	0.00109	CbGpPWpGaD
Dorzolamide—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	3.85e-05	0.00102	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CA5A—glaucoma	3.83e-05	0.00101	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NARFL—glaucoma	3.83e-05	0.00101	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—RPTOR—glaucoma	3.79e-05	0.001	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TXN—glaucoma	3.22e-05	0.000851	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NARFL—glaucoma	3.05e-05	0.000806	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CA5A—glaucoma	3.05e-05	0.000806	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CA5A—glaucoma	2.93e-05	0.000773	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NARFL—glaucoma	2.93e-05	0.000773	CbGpPWpGaD
Dorzolamide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	2.87e-05	0.000759	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NARFL—glaucoma	2.8e-05	0.000741	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CA5A—glaucoma	2.8e-05	0.000741	CbGpPWpGaD
Dorzolamide—CA1—C-MYB transcription factor network—CDKN2A—glaucoma	2.73e-05	0.00072	CbGpPWpGaD
Dorzolamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	2.62e-05	0.000692	CbGpPWpGaD
Dorzolamide—CA1—C-MYB transcription factor network—PTGS2—glaucoma	2.55e-05	0.000674	CbGpPWpGaD
Dorzolamide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	2.54e-05	0.000671	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NARFL—glaucoma	2.47e-05	0.000651	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CA5A—glaucoma	2.47e-05	0.000651	CbGpPWpGaD
Dorzolamide—CA1—C-MYB transcription factor network—CDKN1B—glaucoma	2.41e-05	0.000638	CbGpPWpGaD
Dorzolamide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	2.3e-05	0.000606	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CA1—glaucoma	2.22e-05	0.000586	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CA1—glaucoma	2.16e-05	0.000571	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CA1—glaucoma	2.16e-05	0.000571	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CTSA—glaucoma	2.15e-05	0.000567	CbGpPWpGaD
Dorzolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.14e-05	0.000566	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CTSA—glaucoma	2.09e-05	0.000553	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CTSA—glaucoma	2.09e-05	0.000553	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CA2—glaucoma	2.03e-05	0.000536	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CA1—glaucoma	2.02e-05	0.000533	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CA1—glaucoma	2.02e-05	0.000533	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CA2—glaucoma	1.98e-05	0.000522	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CA2—glaucoma	1.98e-05	0.000522	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CTSA—glaucoma	1.95e-05	0.000516	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CTSA—glaucoma	1.95e-05	0.000516	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	1.92e-05	0.000508	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CA1—glaucoma	1.87e-05	0.000494	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CA2—glaucoma	1.84e-05	0.000487	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CA2—glaucoma	1.84e-05	0.000487	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CTSA—glaucoma	1.81e-05	0.000478	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—SOD1—glaucoma	1.77e-05	0.000469	CbGpPWpGaD
Dorzolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	1.73e-05	0.000456	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CA2—glaucoma	1.71e-05	0.000452	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—CDKN2B—glaucoma	1.68e-05	0.000443	CbGpPWpGaD
Dorzolamide—Tension—Clonidine—glaucoma	1.67e-05	0.000217	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Travoprost—glaucoma	1.67e-05	0.000217	CcSEcCtD
Dorzolamide—Fatigue—Brimonidine—glaucoma	1.67e-05	0.000216	CcSEcCtD
Dorzolamide—Anorexia—Pilocarpine—glaucoma	1.66e-05	0.000215	CcSEcCtD
Dorzolamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.66e-05	0.000439	CbGpPWpGaD
Dorzolamide—Feeling abnormal—Acetazolamide—glaucoma	1.66e-05	0.000215	CcSEcCtD
Dorzolamide—Hypersensitivity—Apraclonidine—glaucoma	1.66e-05	0.000215	CcSEcCtD
Dorzolamide—Nervousness—Clonidine—glaucoma	1.66e-05	0.000214	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Brinzolamide—glaucoma	1.65e-05	0.000214	CcSEcCtD
Dorzolamide—Pain—Brimonidine—glaucoma	1.65e-05	0.000214	CcSEcCtD
Dorzolamide—Visual impairment—Betaxolol—glaucoma	1.64e-05	0.000213	CcSEcCtD
Dorzolamide—Insomnia—Brinzolamide—glaucoma	1.64e-05	0.000212	CcSEcCtD
Dorzolamide—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.64e-05	0.000433	CbGpPWpGaD
Dorzolamide—Dyspnoea—Travoprost—glaucoma	1.64e-05	0.000212	CcSEcCtD
Dorzolamide—Hypotension—Pilocarpine—glaucoma	1.63e-05	0.000211	CcSEcCtD
Dorzolamide—Paraesthesia—Brinzolamide—glaucoma	1.63e-05	0.000211	CcSEcCtD
Dorzolamide—Dysuria—Timolol—glaucoma	1.63e-05	0.000211	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Timolol—glaucoma	1.62e-05	0.000209	CcSEcCtD
Dorzolamide—Dyspnoea—Brinzolamide—glaucoma	1.62e-05	0.000209	CcSEcCtD
Dorzolamide—Dyspepsia—Travoprost—glaucoma	1.62e-05	0.000209	CcSEcCtD
Dorzolamide—Asthenia—Apraclonidine—glaucoma	1.62e-05	0.000209	CcSEcCtD
Dorzolamide—Somnolence—Brinzolamide—glaucoma	1.61e-05	0.000209	CcSEcCtD
Dorzolamide—Vision blurred—Clonidine—glaucoma	1.61e-05	0.000208	CcSEcCtD
Dorzolamide—Erectile dysfunction—Timolol—glaucoma	1.6e-05	0.000208	CcSEcCtD
Dorzolamide—CA9—Cellular responses to stress—IL1A—glaucoma	1.6e-05	0.000423	CbGpPWpGaD
Dorzolamide—Urticaria—Acetazolamide—glaucoma	1.6e-05	0.000207	CcSEcCtD
Dorzolamide—Dyspepsia—Brinzolamide—glaucoma	1.6e-05	0.000207	CcSEcCtD
Dorzolamide—Pruritus—Apraclonidine—glaucoma	1.59e-05	0.000206	CcSEcCtD
Dorzolamide—Body temperature increased—Acetazolamide—glaucoma	1.59e-05	0.000206	CcSEcCtD
Dorzolamide—Tinnitus—Betaxolol—glaucoma	1.59e-05	0.000206	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Pilocarpine—glaucoma	1.59e-05	0.000206	CcSEcCtD
Dorzolamide—Fatigue—Travoprost—glaucoma	1.58e-05	0.000205	CcSEcCtD
Dorzolamide—Insomnia—Pilocarpine—glaucoma	1.58e-05	0.000204	CcSEcCtD
Dorzolamide—Decreased appetite—Brinzolamide—glaucoma	1.58e-05	0.000204	CcSEcCtD
Dorzolamide—Weight decreased—Timolol—glaucoma	1.58e-05	0.000204	CcSEcCtD
Dorzolamide—Pain—Travoprost—glaucoma	1.57e-05	0.000203	CcSEcCtD
Dorzolamide—Hyperglycaemia—Timolol—glaucoma	1.57e-05	0.000203	CcSEcCtD
Dorzolamide—Paraesthesia—Pilocarpine—glaucoma	1.57e-05	0.000203	CcSEcCtD
Dorzolamide—Asthenia—Bimatoprost—glaucoma	1.57e-05	0.000203	CcSEcCtD
Dorzolamide—Fatigue—Brinzolamide—glaucoma	1.56e-05	0.000202	CcSEcCtD
Dorzolamide—Angioedema—Clonidine—glaucoma	1.56e-05	0.000202	CcSEcCtD
Dorzolamide—Dyspnoea—Pilocarpine—glaucoma	1.55e-05	0.000201	CcSEcCtD
Dorzolamide—Pain—Brinzolamide—glaucoma	1.55e-05	0.000201	CcSEcCtD
Dorzolamide—Somnolence—Pilocarpine—glaucoma	1.55e-05	0.000201	CcSEcCtD
Dorzolamide—Depression—Timolol—glaucoma	1.55e-05	0.0002	CcSEcCtD
Dorzolamide—Pruritus—Bimatoprost—glaucoma	1.54e-05	0.0002	CcSEcCtD
Dorzolamide—Diarrhoea—Apraclonidine—glaucoma	1.54e-05	0.000199	CcSEcCtD
Dorzolamide—Dyspepsia—Pilocarpine—glaucoma	1.54e-05	0.000199	CcSEcCtD
Dorzolamide—Syncope—Clonidine—glaucoma	1.53e-05	0.000198	CcSEcCtD
Dorzolamide—Arrhythmia—Betaxolol—glaucoma	1.52e-05	0.000197	CcSEcCtD
Dorzolamide—Decreased appetite—Pilocarpine—glaucoma	1.52e-05	0.000196	CcSEcCtD
Dorzolamide—Feeling abnormal—Travoprost—glaucoma	1.51e-05	0.000196	CcSEcCtD
Dorzolamide—Conjunctivitis—Timolol—glaucoma	1.51e-05	0.000195	CcSEcCtD
Dorzolamide—Alopecia—Betaxolol—glaucoma	1.51e-05	0.000195	CcSEcCtD
Dorzolamide—Palpitations—Clonidine—glaucoma	1.51e-05	0.000195	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Travoprost—glaucoma	1.5e-05	0.000194	CcSEcCtD
Dorzolamide—Loss of consciousness—Clonidine—glaucoma	1.5e-05	0.000194	CcSEcCtD
Dorzolamide—Feeling abnormal—Brinzolamide—glaucoma	1.5e-05	0.000193	CcSEcCtD
Dorzolamide—Pain—Pilocarpine—glaucoma	1.49e-05	0.000193	CcSEcCtD
Dorzolamide—CA4—Metabolism—CA1—glaucoma	1.49e-05	0.000394	CbGpPWpGaD
Dorzolamide—Cough—Clonidine—glaucoma	1.49e-05	0.000193	CcSEcCtD
Dorzolamide—Sweating—Timolol—glaucoma	1.49e-05	0.000193	CcSEcCtD
Dorzolamide—Dizziness—Apraclonidine—glaucoma	1.49e-05	0.000193	CcSEcCtD
Dorzolamide—Erythema—Betaxolol—glaucoma	1.49e-05	0.000192	CcSEcCtD
Dorzolamide—Epistaxis—Timolol—glaucoma	1.47e-05	0.00019	CcSEcCtD
Dorzolamide—Tension—Betaxolol—glaucoma	1.46e-05	0.000189	CcSEcCtD
Dorzolamide—Sinusitis—Timolol—glaucoma	1.46e-05	0.000189	CcSEcCtD
Dorzolamide—Dysgeusia—Betaxolol—glaucoma	1.46e-05	0.000188	CcSEcCtD
Dorzolamide—Arthralgia—Clonidine—glaucoma	1.45e-05	0.000188	CcSEcCtD
Dorzolamide—Chest pain—Clonidine—glaucoma	1.45e-05	0.000188	CcSEcCtD
Dorzolamide—Abdominal pain—Travoprost—glaucoma	1.45e-05	0.000188	CcSEcCtD
Dorzolamide—Agranulocytosis—Timolol—glaucoma	1.45e-05	0.000188	CcSEcCtD
Dorzolamide—Anxiety—Clonidine—glaucoma	1.45e-05	0.000187	CcSEcCtD
Dorzolamide—Asthenia—Acetazolamide—glaucoma	1.44e-05	0.000187	CcSEcCtD
Dorzolamide—Dizziness—Bimatoprost—glaucoma	1.44e-05	0.000187	CcSEcCtD
Dorzolamide—CA4—Metabolism—CTSA—glaucoma	1.44e-05	0.000381	CbGpPWpGaD
Dorzolamide—Nervousness—Betaxolol—glaucoma	1.44e-05	0.000187	CcSEcCtD
Dorzolamide—Urticaria—Brinzolamide—glaucoma	1.44e-05	0.000186	CcSEcCtD
Dorzolamide—Feeling abnormal—Pilocarpine—glaucoma	1.44e-05	0.000186	CcSEcCtD
Dorzolamide—Discomfort—Clonidine—glaucoma	1.44e-05	0.000186	CcSEcCtD
Dorzolamide—Vomiting—Apraclonidine—glaucoma	1.43e-05	0.000185	CcSEcCtD
Dorzolamide—CA2—Metabolism—CA1—glaucoma	1.43e-05	0.000377	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—TXN—glaucoma	1.43e-05	0.000377	CbGpPWpGaD
Dorzolamide—Gastrointestinal pain—Pilocarpine—glaucoma	1.43e-05	0.000185	CcSEcCtD
Dorzolamide—Hypersensitivity—Brimonidine—glaucoma	1.42e-05	0.000184	CcSEcCtD
Dorzolamide—Dry mouth—Clonidine—glaucoma	1.42e-05	0.000184	CcSEcCtD
Dorzolamide—Bradycardia—Timolol—glaucoma	1.42e-05	0.000184	CcSEcCtD
Dorzolamide—Dermatitis—Apraclonidine—glaucoma	1.42e-05	0.000183	CcSEcCtD
Dorzolamide—Headache—Apraclonidine—glaucoma	1.41e-05	0.000182	CcSEcCtD
Dorzolamide—Confusional state—Clonidine—glaucoma	1.4e-05	0.000182	CcSEcCtD
Dorzolamide—Vision blurred—Betaxolol—glaucoma	1.4e-05	0.000181	CcSEcCtD
Dorzolamide—Oedema—Clonidine—glaucoma	1.39e-05	0.00018	CcSEcCtD
Dorzolamide—CA6—Metabolism—TXN—glaucoma	1.39e-05	0.000368	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—TXN—glaucoma	1.39e-05	0.000368	CbGpPWpGaD
Dorzolamide—Hallucination—Timolol—glaucoma	1.39e-05	0.000179	CcSEcCtD
Dorzolamide—Asthenia—Brimonidine—glaucoma	1.39e-05	0.000179	CcSEcCtD
Dorzolamide—CA2—Metabolism—CTSA—glaucoma	1.38e-05	0.000366	CbGpPWpGaD
Dorzolamide—Abdominal pain—Pilocarpine—glaucoma	1.38e-05	0.000178	CcSEcCtD
Dorzolamide—Body temperature increased—Pilocarpine—glaucoma	1.38e-05	0.000178	CcSEcCtD
Dorzolamide—Diarrhoea—Acetazolamide—glaucoma	1.38e-05	0.000178	CcSEcCtD
Dorzolamide—Rash—Bimatoprost—glaucoma	1.38e-05	0.000178	CcSEcCtD
Dorzolamide—Dermatitis—Bimatoprost—glaucoma	1.37e-05	0.000178	CcSEcCtD
Dorzolamide—Shock—Clonidine—glaucoma	1.37e-05	0.000177	CcSEcCtD
Dorzolamide—Pruritus—Brimonidine—glaucoma	1.37e-05	0.000177	CcSEcCtD
Dorzolamide—Headache—Bimatoprost—glaucoma	1.37e-05	0.000177	CcSEcCtD
Dorzolamide—CA4—Metabolism—CA2—glaucoma	1.36e-05	0.00036	CbGpPWpGaD
Dorzolamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	1.36e-05	0.000358	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Travoprost—glaucoma	1.35e-05	0.000175	CcSEcCtD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.35e-05	0.000356	CbGpPWpGaD
Dorzolamide—Hyperhidrosis—Clonidine—glaucoma	1.35e-05	0.000174	CcSEcCtD
Dorzolamide—Visual impairment—Timolol—glaucoma	1.34e-05	0.000174	CcSEcCtD
Dorzolamide—Nausea—Apraclonidine—glaucoma	1.34e-05	0.000173	CcSEcCtD
Dorzolamide—Hypersensitivity—Brinzolamide—glaucoma	1.34e-05	0.000173	CcSEcCtD
Dorzolamide—Vertigo—Betaxolol—glaucoma	1.33e-05	0.000173	CcSEcCtD
Dorzolamide—Syncope—Betaxolol—glaucoma	1.33e-05	0.000172	CcSEcCtD
Dorzolamide—Dizziness—Acetazolamide—glaucoma	1.33e-05	0.000172	CcSEcCtD
Dorzolamide—Anorexia—Clonidine—glaucoma	1.33e-05	0.000172	CcSEcCtD
Dorzolamide—CA1—Metabolism—CTSA—glaucoma	1.33e-05	0.00035	CbGpPWpGaD
Dorzolamide—Asthenia—Travoprost—glaucoma	1.32e-05	0.000171	CcSEcCtD
Dorzolamide—Palpitations—Betaxolol—glaucoma	1.31e-05	0.00017	CcSEcCtD
Dorzolamide—Loss of consciousness—Betaxolol—glaucoma	1.31e-05	0.000169	CcSEcCtD
Dorzolamide—Asthenia—Brinzolamide—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—Hypotension—Clonidine—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—Pruritus—Travoprost—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—Tinnitus—Timolol—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—CA7—Metabolism—TXN—glaucoma	1.3e-05	0.000343	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—TXN—glaucoma	1.3e-05	0.000343	CbGpPWpGaD
Dorzolamide—Cough—Betaxolol—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—Nausea—Bimatoprost—glaucoma	1.3e-05	0.000168	CcSEcCtD
Dorzolamide—Hypersensitivity—Pilocarpine—glaucoma	1.29e-05	0.000166	CcSEcCtD
Dorzolamide—Pruritus—Brinzolamide—glaucoma	1.28e-05	0.000166	CcSEcCtD
Dorzolamide—Vomiting—Acetazolamide—glaucoma	1.28e-05	0.000166	CcSEcCtD
Dorzolamide—Dizziness—Brimonidine—glaucoma	1.28e-05	0.000165	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Clonidine—glaucoma	1.27e-05	0.000164	CcSEcCtD
Dorzolamide—Arthralgia—Betaxolol—glaucoma	1.26e-05	0.000164	CcSEcCtD
Dorzolamide—Chest pain—Betaxolol—glaucoma	1.26e-05	0.000164	CcSEcCtD
Dorzolamide—Headache—Acetazolamide—glaucoma	1.26e-05	0.000163	CcSEcCtD
Dorzolamide—Anxiety—Betaxolol—glaucoma	1.26e-05	0.000163	CcSEcCtD
Dorzolamide—Insomnia—Clonidine—glaucoma	1.26e-05	0.000163	CcSEcCtD
Dorzolamide—Diarrhoea—Travoprost—glaucoma	1.26e-05	0.000163	CcSEcCtD
Dorzolamide—CA1—Metabolism—CA2—glaucoma	1.25e-05	0.000331	CbGpPWpGaD
Dorzolamide—Asthenia—Pilocarpine—glaucoma	1.25e-05	0.000162	CcSEcCtD
Dorzolamide—Paraesthesia—Clonidine—glaucoma	1.25e-05	0.000162	CcSEcCtD
Dorzolamide—Discomfort—Betaxolol—glaucoma	1.25e-05	0.000162	CcSEcCtD
Dorzolamide—Arrhythmia—Timolol—glaucoma	1.25e-05	0.000161	CcSEcCtD
Dorzolamide—Dyspnoea—Clonidine—glaucoma	1.24e-05	0.000161	CcSEcCtD
Dorzolamide—Diarrhoea—Brinzolamide—glaucoma	1.24e-05	0.000161	CcSEcCtD
Dorzolamide—Somnolence—Clonidine—glaucoma	1.24e-05	0.00016	CcSEcCtD
Dorzolamide—Dry mouth—Betaxolol—glaucoma	1.24e-05	0.00016	CcSEcCtD
Dorzolamide—Pruritus—Pilocarpine—glaucoma	1.23e-05	0.00016	CcSEcCtD
Dorzolamide—Alopecia—Timolol—glaucoma	1.23e-05	0.000159	CcSEcCtD
Dorzolamide—Confusional state—Betaxolol—glaucoma	1.22e-05	0.000158	CcSEcCtD
Dorzolamide—Rash—Brimonidine—glaucoma	1.22e-05	0.000158	CcSEcCtD
Dorzolamide—Dermatitis—Brimonidine—glaucoma	1.22e-05	0.000158	CcSEcCtD
Dorzolamide—Dizziness—Travoprost—glaucoma	1.22e-05	0.000157	CcSEcCtD
Dorzolamide—Erythema—Timolol—glaucoma	1.21e-05	0.000157	CcSEcCtD
Dorzolamide—Oedema—Betaxolol—glaucoma	1.21e-05	0.000157	CcSEcCtD
Dorzolamide—Headache—Brimonidine—glaucoma	1.21e-05	0.000157	CcSEcCtD
Dorzolamide—Decreased appetite—Clonidine—glaucoma	1.21e-05	0.000157	CcSEcCtD
Dorzolamide—CA9—Metabolism—CA1—glaucoma	1.2e-05	0.000318	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—TXN—glaucoma	1.2e-05	0.000318	CbGpPWpGaD
Dorzolamide—Fatigue—Clonidine—glaucoma	1.2e-05	0.000155	CcSEcCtD
Dorzolamide—Dizziness—Brinzolamide—glaucoma	1.2e-05	0.000155	CcSEcCtD
Dorzolamide—Nausea—Acetazolamide—glaucoma	1.2e-05	0.000155	CcSEcCtD
Dorzolamide—Diarrhoea—Pilocarpine—glaucoma	1.19e-05	0.000154	CcSEcCtD
Dorzolamide—Shock—Betaxolol—glaucoma	1.19e-05	0.000154	CcSEcCtD
Dorzolamide—Tension—Timolol—glaucoma	1.19e-05	0.000154	CcSEcCtD
Dorzolamide—Pain—Clonidine—glaucoma	1.19e-05	0.000154	CcSEcCtD
Dorzolamide—Dysgeusia—Timolol—glaucoma	1.19e-05	0.000154	CcSEcCtD
Dorzolamide—Nervousness—Timolol—glaucoma	1.18e-05	0.000153	CcSEcCtD
Dorzolamide—Hyperhidrosis—Betaxolol—glaucoma	1.17e-05	0.000152	CcSEcCtD
Dorzolamide—CA9—Metabolism—CTSA—glaucoma	1.17e-05	0.000308	CbGpPWpGaD
Dorzolamide—Rash—Travoprost—glaucoma	1.16e-05	0.00015	CcSEcCtD
Dorzolamide—Dermatitis—Travoprost—glaucoma	1.16e-05	0.00015	CcSEcCtD
Dorzolamide—Anorexia—Betaxolol—glaucoma	1.16e-05	0.00015	CcSEcCtD
Dorzolamide—Vomiting—Brinzolamide—glaucoma	1.15e-05	0.000149	CcSEcCtD
Dorzolamide—Dizziness—Pilocarpine—glaucoma	1.15e-05	0.000149	CcSEcCtD
Dorzolamide—Headache—Travoprost—glaucoma	1.15e-05	0.000149	CcSEcCtD
Dorzolamide—Nausea—Brimonidine—glaucoma	1.15e-05	0.000149	CcSEcCtD
Dorzolamide—Feeling abnormal—Clonidine—glaucoma	1.15e-05	0.000148	CcSEcCtD
Dorzolamide—Rash—Brinzolamide—glaucoma	1.14e-05	0.000148	CcSEcCtD
Dorzolamide—Vision blurred—Timolol—glaucoma	1.14e-05	0.000148	CcSEcCtD
Dorzolamide—Dermatitis—Brinzolamide—glaucoma	1.14e-05	0.000148	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Clonidine—glaucoma	1.14e-05	0.000147	CcSEcCtD
Dorzolamide—Headache—Brinzolamide—glaucoma	1.14e-05	0.000147	CcSEcCtD
Dorzolamide—Hypotension—Betaxolol—glaucoma	1.13e-05	0.000147	CcSEcCtD
Dorzolamide—Angioedema—Timolol—glaucoma	1.11e-05	0.000143	CcSEcCtD
Dorzolamide—Vomiting—Pilocarpine—glaucoma	1.11e-05	0.000143	CcSEcCtD
Dorzolamide—CA14—Metabolism—GSTT1—glaucoma	1.11e-05	0.000293	CbGpPWpGaD
Dorzolamide—Urticaria—Clonidine—glaucoma	1.11e-05	0.000143	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Betaxolol—glaucoma	1.1e-05	0.000143	CcSEcCtD
Dorzolamide—CA9—Metabolism—CA2—glaucoma	1.1e-05	0.000291	CbGpPWpGaD
Dorzolamide—Body temperature increased—Clonidine—glaucoma	1.1e-05	0.000142	CcSEcCtD
Dorzolamide—Abdominal pain—Clonidine—glaucoma	1.1e-05	0.000142	CcSEcCtD
Dorzolamide—Rash—Pilocarpine—glaucoma	1.1e-05	0.000142	CcSEcCtD
Dorzolamide—Dermatitis—Pilocarpine—glaucoma	1.1e-05	0.000142	CcSEcCtD
Dorzolamide—Insomnia—Betaxolol—glaucoma	1.1e-05	0.000142	CcSEcCtD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.1e-05	0.00029	CbGpPWpGaD
Dorzolamide—Headache—Pilocarpine—glaucoma	1.09e-05	0.000141	CcSEcCtD
Dorzolamide—Nausea—Travoprost—glaucoma	1.09e-05	0.000141	CcSEcCtD
Dorzolamide—Vertigo—Timolol—glaucoma	1.09e-05	0.000141	CcSEcCtD
Dorzolamide—Paraesthesia—Betaxolol—glaucoma	1.09e-05	0.000141	CcSEcCtD
Dorzolamide—Syncope—Timolol—glaucoma	1.09e-05	0.000141	CcSEcCtD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.08e-05	0.000286	CbGpPWpGaD
Dorzolamide—Dyspnoea—Betaxolol—glaucoma	1.08e-05	0.00014	CcSEcCtD
Dorzolamide—CA6—Metabolism—GSTT1—glaucoma	1.08e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTT1—glaucoma	1.08e-05	0.000285	CbGpPWpGaD
Dorzolamide—Nausea—Brinzolamide—glaucoma	1.08e-05	0.000139	CcSEcCtD
Dorzolamide—Palpitations—Timolol—glaucoma	1.07e-05	0.000139	CcSEcCtD
Dorzolamide—Dyspepsia—Betaxolol—glaucoma	1.07e-05	0.000138	CcSEcCtD
Dorzolamide—Loss of consciousness—Timolol—glaucoma	1.07e-05	0.000138	CcSEcCtD
Dorzolamide—Cough—Timolol—glaucoma	1.06e-05	0.000137	CcSEcCtD
Dorzolamide—Decreased appetite—Betaxolol—glaucoma	1.05e-05	0.000136	CcSEcCtD
Dorzolamide—Hypertension—Timolol—glaucoma	1.05e-05	0.000136	CcSEcCtD
Dorzolamide—Fatigue—Betaxolol—glaucoma	1.05e-05	0.000135	CcSEcCtD
Dorzolamide—Pain—Betaxolol—glaucoma	1.04e-05	0.000134	CcSEcCtD
Dorzolamide—Nausea—Pilocarpine—glaucoma	1.04e-05	0.000134	CcSEcCtD
Dorzolamide—Arthralgia—Timolol—glaucoma	1.03e-05	0.000134	CcSEcCtD
Dorzolamide—Chest pain—Timolol—glaucoma	1.03e-05	0.000134	CcSEcCtD
Dorzolamide—Anxiety—Timolol—glaucoma	1.03e-05	0.000133	CcSEcCtD
Dorzolamide—Hypersensitivity—Clonidine—glaucoma	1.03e-05	0.000133	CcSEcCtD
Dorzolamide—Discomfort—Timolol—glaucoma	1.02e-05	0.000132	CcSEcCtD
Dorzolamide—Dry mouth—Timolol—glaucoma	1.01e-05	0.000131	CcSEcCtD
Dorzolamide—CA5B—Metabolism—GSTT1—glaucoma	1.01e-05	0.000266	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTT1—glaucoma	1.01e-05	0.000266	CbGpPWpGaD
Dorzolamide—Asthenia—Clonidine—glaucoma	9.99e-06	0.000129	CcSEcCtD
Dorzolamide—Feeling abnormal—Betaxolol—glaucoma	9.99e-06	0.000129	CcSEcCtD
Dorzolamide—Confusional state—Timolol—glaucoma	9.99e-06	0.000129	CcSEcCtD
Dorzolamide—Anaphylactic shock—Timolol—glaucoma	9.91e-06	0.000128	CcSEcCtD
Dorzolamide—Oedema—Timolol—glaucoma	9.91e-06	0.000128	CcSEcCtD
Dorzolamide—Pruritus—Clonidine—glaucoma	9.85e-06	0.000127	CcSEcCtD
Dorzolamide—Shock—Timolol—glaucoma	9.75e-06	0.000126	CcSEcCtD
Dorzolamide—Urticaria—Betaxolol—glaucoma	9.63e-06	0.000125	CcSEcCtD
Dorzolamide—CA4—Metabolism—TXN—glaucoma	9.6e-06	0.000254	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—CDKN2A—glaucoma	9.59e-06	0.000253	CbGpPWpGaD
Dorzolamide—Body temperature increased—Betaxolol—glaucoma	9.59e-06	0.000124	CcSEcCtD
Dorzolamide—Hyperhidrosis—Timolol—glaucoma	9.58e-06	0.000124	CcSEcCtD
Dorzolamide—Diarrhoea—Clonidine—glaucoma	9.53e-06	0.000123	CcSEcCtD
Dorzolamide—Anorexia—Timolol—glaucoma	9.44e-06	0.000122	CcSEcCtD
Dorzolamide—CA12—Metabolism—GSTT1—glaucoma	9.34e-06	0.000247	CbGpPWpGaD
Dorzolamide—Hypotension—Timolol—glaucoma	9.26e-06	0.00012	CcSEcCtD
Dorzolamide—Dizziness—Clonidine—glaucoma	9.21e-06	0.000119	CcSEcCtD
Dorzolamide—CA2—Metabolism—TXN—glaucoma	9.21e-06	0.000243	CbGpPWpGaD
Dorzolamide—Musculoskeletal discomfort—Timolol—glaucoma	9.03e-06	0.000117	CcSEcCtD
Dorzolamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	8.98e-06	0.000237	CbGpPWpGaD
Dorzolamide—Insomnia—Timolol—glaucoma	8.96e-06	0.000116	CcSEcCtD
Dorzolamide—Hypersensitivity—Betaxolol—glaucoma	8.93e-06	0.000116	CcSEcCtD
Dorzolamide—Paraesthesia—Timolol—glaucoma	8.9e-06	0.000115	CcSEcCtD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.88e-06	0.000235	CbGpPWpGaD
Dorzolamide—Vomiting—Clonidine—glaucoma	8.86e-06	0.000115	CcSEcCtD
Dorzolamide—Dyspnoea—Timolol—glaucoma	8.83e-06	0.000114	CcSEcCtD
Dorzolamide—CA14—Metabolism—ABCA1—glaucoma	8.83e-06	0.000233	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—TXN—glaucoma	8.83e-06	0.000233	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1B1—glaucoma	8.83e-06	0.000233	CbGpPWpGaD
Dorzolamide—Somnolence—Timolol—glaucoma	8.81e-06	0.000114	CcSEcCtD
Dorzolamide—Rash—Clonidine—glaucoma	8.78e-06	0.000114	CcSEcCtD
Dorzolamide—Dermatitis—Clonidine—glaucoma	8.77e-06	0.000114	CcSEcCtD
Dorzolamide—Headache—Clonidine—glaucoma	8.73e-06	0.000113	CcSEcCtD
Dorzolamide—Dyspepsia—Timolol—glaucoma	8.72e-06	0.000113	CcSEcCtD
Dorzolamide—Asthenia—Betaxolol—glaucoma	8.7e-06	0.000113	CcSEcCtD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	8.67e-06	0.000229	CbGpPWpGaD
Dorzolamide—Decreased appetite—Timolol—glaucoma	8.61e-06	0.000111	CcSEcCtD
Dorzolamide—CA5A—Metabolism—ABCA1—glaucoma	8.6e-06	0.000227	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1B1—glaucoma	8.6e-06	0.000227	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1B1—glaucoma	8.6e-06	0.000227	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ABCA1—glaucoma	8.6e-06	0.000227	CbGpPWpGaD
Dorzolamide—Pruritus—Betaxolol—glaucoma	8.58e-06	0.000111	CcSEcCtD
Dorzolamide—Fatigue—Timolol—glaucoma	8.54e-06	0.00011	CcSEcCtD
Dorzolamide—CA9—Cellular responses to stress—CDKN1B—glaucoma	8.49e-06	0.000224	CbGpPWpGaD
Dorzolamide—Pain—Timolol—glaucoma	8.47e-06	0.00011	CcSEcCtD
Dorzolamide—Diarrhoea—Betaxolol—glaucoma	8.3e-06	0.000107	CcSEcCtD
Dorzolamide—Nausea—Clonidine—glaucoma	8.27e-06	0.000107	CcSEcCtD
Dorzolamide—Feeling abnormal—Timolol—glaucoma	8.16e-06	0.000106	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Timolol—glaucoma	8.1e-06	0.000105	CcSEcCtD
Dorzolamide—CA5B—Metabolism—CYP1B1—glaucoma	8.03e-06	0.000212	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ABCA1—glaucoma	8.03e-06	0.000212	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ABCA1—glaucoma	8.03e-06	0.000212	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1B1—glaucoma	8.03e-06	0.000212	CbGpPWpGaD
Dorzolamide—Dizziness—Betaxolol—glaucoma	8.02e-06	0.000104	CcSEcCtD
Dorzolamide—Urticaria—Timolol—glaucoma	7.87e-06	0.000102	CcSEcCtD
Dorzolamide—Abdominal pain—Timolol—glaucoma	7.83e-06	0.000101	CcSEcCtD
Dorzolamide—Body temperature increased—Timolol—glaucoma	7.83e-06	0.000101	CcSEcCtD
Dorzolamide—CA9—Metabolism—TXN—glaucoma	7.76e-06	0.000205	CbGpPWpGaD
Dorzolamide—Vomiting—Betaxolol—glaucoma	7.71e-06	9.97e-05	CcSEcCtD
Dorzolamide—Rash—Betaxolol—glaucoma	7.65e-06	9.89e-05	CcSEcCtD
Dorzolamide—Dermatitis—Betaxolol—glaucoma	7.64e-06	9.88e-05	CcSEcCtD
Dorzolamide—Headache—Betaxolol—glaucoma	7.6e-06	9.83e-05	CcSEcCtD
Dorzolamide—CA4—Metabolism—GSTT1—glaucoma	7.45e-06	0.000197	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCA1—glaucoma	7.44e-06	0.000197	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1B1—glaucoma	7.44e-06	0.000197	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Timolol—glaucoma	7.3e-06	9.44e-05	CcSEcCtD
Dorzolamide—Nausea—Betaxolol—glaucoma	7.2e-06	9.32e-05	CcSEcCtD
Dorzolamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	7.16e-06	0.000189	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTT1—glaucoma	7.14e-06	0.000189	CbGpPWpGaD
Dorzolamide—Asthenia—Timolol—glaucoma	7.11e-06	9.19e-05	CcSEcCtD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—glaucoma	7.06e-06	0.000187	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	7.06e-06	0.000186	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GSTM1—glaucoma	7.06e-06	0.000186	CbGpPWpGaD
Dorzolamide—Pruritus—Timolol—glaucoma	7.01e-06	9.07e-05	CcSEcCtD
Dorzolamide—CA5A—Metabolism—GSTM1—glaucoma	6.88e-06	0.000182	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTM1—glaucoma	6.88e-06	0.000182	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTT1—glaucoma	6.84e-06	0.000181	CbGpPWpGaD
Dorzolamide—Diarrhoea—Timolol—glaucoma	6.78e-06	8.77e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.68e-06	0.000177	CbGpPWpGaD
Dorzolamide—Dizziness—Timolol—glaucoma	6.55e-06	8.47e-05	CcSEcCtD
Dorzolamide—CA5B—Metabolism—GSTM1—glaucoma	6.42e-06	0.00017	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTM1—glaucoma	6.42e-06	0.00017	CbGpPWpGaD
Dorzolamide—Vomiting—Timolol—glaucoma	6.3e-06	8.15e-05	CcSEcCtD
Dorzolamide—CYP2C9—Metabolism—NARFL—glaucoma	6.29e-06	0.000166	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA5A—glaucoma	6.29e-06	0.000166	CbGpPWpGaD
Dorzolamide—Rash—Timolol—glaucoma	6.25e-06	8.08e-05	CcSEcCtD
Dorzolamide—Dermatitis—Timolol—glaucoma	6.24e-06	8.07e-05	CcSEcCtD
Dorzolamide—CA14—Metabolism—MTHFR—glaucoma	6.24e-06	0.000165	CbGpPWpGaD
Dorzolamide—Headache—Timolol—glaucoma	6.21e-06	8.03e-05	CcSEcCtD
Dorzolamide—CA6—Metabolism—MTHFR—glaucoma	6.08e-06	0.000161	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—MTHFR—glaucoma	6.08e-06	0.000161	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTT1—glaucoma	6.02e-06	0.000159	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTM1—glaucoma	5.95e-06	0.000157	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCA1—glaucoma	5.93e-06	0.000157	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1B1—glaucoma	5.93e-06	0.000157	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.92e-06	0.000156	CbGpPWpGaD
Dorzolamide—Nausea—Timolol—glaucoma	5.88e-06	7.61e-05	CcSEcCtD
Dorzolamide—CA14—Metabolism—APOE—glaucoma	5.81e-06	0.000153	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CAV1—glaucoma	5.75e-06	0.000152	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.72e-06	0.000151	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1B1—glaucoma	5.69e-06	0.00015	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCA1—glaucoma	5.69e-06	0.00015	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—MTHFR—glaucoma	5.67e-06	0.00015	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—MTHFR—glaucoma	5.67e-06	0.00015	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—APOE—glaucoma	5.66e-06	0.000149	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—APOE—glaucoma	5.66e-06	0.000149	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.64e-06	0.000149	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CAV1—glaucoma	5.61e-06	0.000148	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CAV1—glaucoma	5.61e-06	0.000148	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCA1—glaucoma	5.45e-06	0.000144	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1B1—glaucoma	5.45e-06	0.000144	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—glaucoma	5.34e-06	0.000141	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—APOE—glaucoma	5.28e-06	0.00014	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—APOE—glaucoma	5.28e-06	0.00014	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—MTHFR—glaucoma	5.26e-06	0.000139	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CAV1—glaucoma	5.23e-06	0.000138	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CAV1—glaucoma	5.23e-06	0.000138	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—APOE—glaucoma	4.89e-06	0.000129	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CAV1—glaucoma	4.85e-06	0.000128	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCA1—glaucoma	4.79e-06	0.000127	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1B1—glaucoma	4.79e-06	0.000127	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—glaucoma	4.74e-06	0.000125	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.72e-06	0.000125	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.65e-06	0.000123	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTM1—glaucoma	4.55e-06	0.00012	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—glaucoma	4.36e-06	0.000115	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NOS3—glaucoma	4.35e-06	0.000115	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NOS3—glaucoma	4.24e-06	0.000112	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NOS3—glaucoma	4.24e-06	0.000112	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—glaucoma	4.19e-06	0.000111	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NARFL—glaucoma	4.15e-06	0.00011	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA5A—glaucoma	4.15e-06	0.00011	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—glaucoma	4.02e-06	0.000106	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—glaucoma	3.98e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NOS3—glaucoma	3.96e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NOS3—glaucoma	3.96e-06	0.000105	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOE—glaucoma	3.9e-06	0.000103	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—glaucoma	3.88e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—glaucoma	3.88e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CAV1—glaucoma	3.87e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—glaucoma	3.85e-06	0.000102	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—glaucoma	3.83e-06	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.77e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOE—glaucoma	3.74e-06	9.88e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.72e-06	9.83e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CAV1—glaucoma	3.71e-06	9.79e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—glaucoma	3.67e-06	9.69e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—glaucoma	3.62e-06	9.56e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—glaucoma	3.62e-06	9.56e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOE—glaucoma	3.59e-06	9.48e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CAV1—glaucoma	3.55e-06	9.39e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—glaucoma	3.39e-06	8.95e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—glaucoma	3.35e-06	8.86e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—glaucoma	3.15e-06	8.33e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CAV1—glaucoma	3.12e-06	8.25e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA1—glaucoma	3.07e-06	8.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CTSA—glaucoma	2.98e-06	7.86e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—glaucoma	2.92e-06	7.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA2—glaucoma	2.81e-06	7.43e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—glaucoma	2.8e-06	7.4e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.75e-06	7.26e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.75e-06	7.26e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—glaucoma	2.69e-06	7.1e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—glaucoma	2.67e-06	7.06e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—glaucoma	2.56e-06	6.77e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—glaucoma	2.46e-06	6.49e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—glaucoma	2.36e-06	6.24e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—glaucoma	2.16e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA1—glaucoma	2.03e-06	5.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TXN—glaucoma	1.98e-06	5.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CTSA—glaucoma	1.96e-06	5.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA2—glaucoma	1.85e-06	4.9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.81e-06	4.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.79e-06	4.73e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—glaucoma	1.54e-06	4.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TXN—glaucoma	1.31e-06	3.45e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.24e-06	3.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1B1—glaucoma	1.22e-06	3.23e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCA1—glaucoma	1.22e-06	3.23e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—glaucoma	1.01e-06	2.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—glaucoma	9.78e-07	2.58e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—glaucoma	8.65e-07	2.28e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCA1—glaucoma	8.07e-07	2.13e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1B1—glaucoma	8.07e-07	2.13e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—glaucoma	8.05e-07	2.13e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAV1—glaucoma	7.97e-07	2.11e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—glaucoma	6.45e-07	1.7e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—glaucoma	6.03e-07	1.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—glaucoma	5.7e-07	1.51e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—glaucoma	5.52e-07	1.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—glaucoma	5.31e-07	1.4e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAV1—glaucoma	5.26e-07	1.39e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—glaucoma	3.98e-07	1.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—glaucoma	3.64e-07	9.61e-06	CbGpPWpGaD
